Cite
HARVARD Citation
Kaine, J. et al. (2012). Evaluation of abatacept administered subcutaneously in adults with active rheumatoid arthritis: impact of withdrawal and reintroduction on immunogenicity, efficacy and safety (phase Iiib ALLOW study). Annals of the rheumatic diseases. 71 (1), pp. 38-44. [Online].